NCT03187925 Cricopharyngeal Dysfunction and Esophageal Diverticulum
| NCT ID | NCT03187925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Zenker Diverticulum |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-08-15 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-08-15 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients with a diagnosis of cervical esophageal diverticulum, with Zenker's as most common, or CP bar (with diagnosis of early Zenker) as indicated on an esophagram who the participating institutions enroll regardless of surgical management and future treatments. Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up. Exclusion Criteria: * Patients who undergo division of the common wall between the diverticulum and esophagus using flexible endoscopy will not be included in the study.
Contact & Investigator
Rebecca J Howell, MD
PRINCIPAL INVESTIGATOR
University of Cincinnati
Frequently Asked Questions
Who can join the NCT03187925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Zenker Diverticulum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03187925 currently recruiting?
Yes, NCT03187925 is actively recruiting participants. Contact the research team at gibsonrk@uc.edu for enrollment information.
Where is the NCT03187925 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT03187925 clinical trial?
NCT03187925 is sponsored by University of Cincinnati. The principal investigator is Rebecca J Howell, MD at University of Cincinnati. The trial plans to enroll 500 participants.